甲基甲酸的毒性:一个务实的方法.
1Division of Renal Diseases and Hypertension, Department of Internal Medicine, University of Texas Health Science Center-McGovern Medical School, Houston, Texas, USA.
Current opinion in nephrology and hypertension
|December 8, 2025
概括
管理高剂量甲基酸盐 (HDMTX) 毒性需要个性化策略. 新兴的风险因素和先进的监测,包括药物基因组学和药物动力学建模,是减少功能障碍和延迟甲状腺除 (DME) 的关键.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 高剂量甲状腺素 (HDMTX) 对于治疗各种癌症至关重要.
- 针对HDMTX毒性的预防措施经常失败,导致功能障碍和延迟甲状腺除 (DME),增加全身毒性风险.
研究的目的:
- 审查现有的,当前的和新的策略来管理与HDMTX相关的毒性.
- 突出了解和减轻HDMTX诱导的并发症的进展.
主要方法:
- 对 HDMTX 毒性的过去,当前和新兴管理策略的文献综述.
- 对风险因素,保护剂和监测工具的最新研究进行分析.
主要成果:
- 主体遗传因素,低albuminemia和身体表面积被确定为DME贡献者.
- 研究的脏保护剂包括合成氧沙 (5b),empagliflozin和amlodipine.
- 葡萄糖酶显示改善结果和脏恢复;早期治疗药物监测预测脏损伤;MTXPK.org有助于DME管理.
结论:
- 个性化治疗策略对于减少毒性和DME至关重要.
- 药物基因组学,风险因素识别和药物动力学建模方面的进展至关重要.
- 及时的甲状腺素监测和患者特定的建模改善了治疗结果.
相关概念视频
Therapeutic Drug Monitoring: Affecting Factors
182
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
182
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
196
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
196
Kidney Transplant II: Surgical Procedure
289
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
289
Acute Kidney Injury IV: Diagnostic Studies and Prevention
244
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
244
Renal Failure: Dose Adjustments
407
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
407
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
461
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
461


